BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34678454)

  • 1. Biodegradability, environmental risk assessment and ecological footprint in wastewater technologies for pharmaceutically active compounds removal.
    Dos Santos CR; Lebron YAR; Moreira VR; Koch K; Amaral MCS
    Bioresour Technol; 2022 Jan; 343():126150. PubMed ID: 34678454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutically active compounds in aqueous environment: recent developments in their fate, occurrence and elimination for efficient water purification.
    Bangia S; Bangia R; Daverey A
    Environ Monit Assess; 2023 Oct; 195(11):1344. PubMed ID: 37857877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
    Nguyen PY; Carvalho G; Reis MAM; Oehmen A
    Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
    Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
    Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase enzymes.
    Naghdi M; Taheran M; Brar SK; Kermanshahi-Pour A; Verma M; Surampalli RY
    Environ Pollut; 2018 Mar; 234():190-213. PubMed ID: 29175684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: mass balance analysis and consumption back-calculated model.
    Yan Q; Gao X; Huang L; Gan XM; Zhang YX; Chen YP; Peng XY; Guo JS
    Chemosphere; 2014 Mar; 99():160-70. PubMed ID: 24268750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of some factors affecting pharmaceutical active compounds (PhACs) removal in real wastewater. Case study of fungal treatment of reverse osmosis concentrate.
    Badia-Fabregat M; Lucas D; Gros M; Rodríguez-Mozaz S; Barceló D; Caminal G; Vicent T
    J Hazard Mater; 2015; 283():663-71. PubMed ID: 25464308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence, fate, and potential risk of pharmaceutical pollutants in agriculture: Challenges and environmentally friendly solutions.
    Nguyen MK; Lin C; Nguyen HL; Hung NTQ; La DD; Nguyen XH; Chang SW; Chung WJ; Nguyen DD
    Sci Total Environ; 2023 Nov; 899():165323. PubMed ID: 37422238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
    Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-treatment of real municipal wastewater effluents by means of granular activated carbon (GAC) based catalytic processes: A focus on abatement of pharmaceutically active compounds.
    Rueda-Márquez JJ; Moreno-Andrés J; Rey A; Corada-Fernández C; Mikola A; Manzano MA; Levchuk I
    Water Res; 2021 Mar; 192():116833. PubMed ID: 33486287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced biological activated carbon filter for removing pharmaceutically active compounds from treated wastewater.
    Sbardella L; Comas J; Fenu A; Rodriguez-Roda I; Weemaes M
    Sci Total Environ; 2018 Sep; 636():519-529. PubMed ID: 29715656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of advanced biological treatment and nature-based solutions for the treatment of pharmaceutically active compounds (PhACs): A comprehensive study for wastewater and sewage sludge.
    Nas B; Dolu T; Argun ME; Yel E; Ateş H; Koyuncu S
    Sci Total Environ; 2021 Jul; 779():146344. PubMed ID: 34030227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sorption processes in the removal of pharmaceuticals by fungal treatment of wastewater.
    Lucas D; Castellet-Rovira F; Villagrasa M; Badia-Fabregat M; Barceló D; Vicent T; Caminal G; Sarrà M; Rodríguez-Mozaz S
    Sci Total Environ; 2018 Jan; 610-611():1147-1153. PubMed ID: 28847135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
    Ying GG; Kookana RS; Kolpin DW
    J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and fate of pharmaceutical pollutants in wastewater: Insights on ecotoxicity, health risk, and state-of-the-art removal.
    Nguyen MK; Lin C; Bui XT; Rakib MRJ; Nguyen HL; Truong QM; Hoang HG; Tran HT; Malafaia G; Idris AM
    Chemosphere; 2024 Apr; 354():141678. PubMed ID: 38485003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutically active compounds: Their removal during slow sand filtration and their impact on slow sand filtration bacterial removal.
    D'Alessio M; Yoneyama B; Kirs M; Kisand V; Ray C
    Sci Total Environ; 2015 Aug; 524-525():124-35. PubMed ID: 25889551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving biological removal of pharmaceutical active compounds and estrogenic activity in a mesophilic anaerobic osmotic membrane bioreactor treating municipal sewage.
    Arcanjo GS; Dos Santos CR; Cavalcante BF; Moura GA; Ricci BC; Mounteer AH; Santos LVS; Queiroz LM; Amaral MC
    Chemosphere; 2022 Aug; 301():134716. PubMed ID: 35487362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms.
    Yan Q; Min J; Yu Y; Zhu Z; Feng G
    Chemosphere; 2017 Nov; 186():823-831. PubMed ID: 28826130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies.
    Maeng SK; Sharma SK; Abel CD; Magic-Knezev A; Amy GL
    Water Res; 2011 Oct; 45(16):4722-36. PubMed ID: 21802106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.